Category: Home

Coenzyme Q aging

Coenzyme Q aging

Tert-butyl hydroperoxide was used to construct Coezyme standard curve. Purchase Advertise Advertising and Caffeine supplement pills Services Advertising Mediakit Coenzmye and ePrints Sponsored Supplements Journals Career Network About About The Journals of Gerontology, Agung A About The Gerontological Water jug refill Coenzyme Q aging America Editorial Coenzyme Q aging Digestive health promoting habits Biological Sciences Editorial Board qging Medical Sciences Alerts Coenzyje Policy Dispatch Dates Terms and Conditions Contact Us GSA Journals Close Navbar Search Filter The Journals of Gerontology: Series A This issue GSA Journals Biological Sciences Geriatric Medicine Books Journals Oxford Academic Enter search term Search. All experiments were performed at least in three biological replicates conducted in different experimental sessions. About us About us. High cholesterol People with high cholesterol tend to have lower levels of CoQ10, so CoQ10 has been proposed as a treatment for high cholesterol, but scientific studies are lacking. The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA A to G mutation. Free Radic Biol Med.

Coenzyme Q aging -

The ETC complexes are assembled into respiratory supercomplexes in order to function efficiently and prevent electron leakage to oxygen that ultimately results in the production of reactive oxygen species ROS Genova and Lenaz, ; Guo et al.

Mitochondrial CoQ may be associated in discrete pools dedicated to either NADH-coupled or FADH 2 -coupled electron transport Lapuente-Brun et al.

Complex I stability is determined by CoQ redox state Guaras et al. Mitochondrial activities such as the dihydroorotate dehydrogenase, β-oxidation of fatty acids, and mitochondrial glycerolphosphate dehydrogenase contribute also to the increase in CoQH 2 levels Alcazar-Fabra et al.

Figure 1. The multiple functions of CoQ A Mitochondria. By transferring two electrons to CIII, the reduced form of CoQ 10 ubiquinol is oxidized to ubiquinone. B Cell membrane activities of CoQ Present in nearly all cellular membranes, CoQ 10 offers antioxidant protection, in part, by maintaining the reduced state of α-tocopherol α-TOC and ascorbic acid ASC.

Furthermore, CoQ 10 also regulates apoptosis by preventing lipid peroxidation. Other functions of CoQ 10 in cell membrane include metabolic regulation, cell signaling, and cell growth through local regulation of cytosolic redox intermediates such as NAD P H López-Lluch et al.

CoQ provides antioxidant protection to cell membranes and plasma lipoproteins López-Lluch et al. By lowering lipid peroxidation of low-density lipoprotein LDL particles that contributes to atherosclerosis Thomas et al. The anti-oxidant function of CoQ is especially important in the plasma membrane by reducing vitamins C and E, and in preventing ceramide-mediated apoptosis Navas et al.

It has been proposed that NAD P H:quinone oxidoreductase 1 NQO1 acts as a redox-sensitive switch to regulate the response of cells to changes in the redox environment Ross and Siegel, The pharmacokinetics variability of the different compositions of CoQ 10 may result in fairly different plasma concentration-time profiles after CoQ 10 administration Weis et al.

Indeed, the major amount of orally supplemented CoQ 10 is eliminated via feces, with only a fraction of ingested CoQ 10 reaching the blood and ultimately the various tissues and organs Bentinger et al.

For these reasons, CoQ appears suitable for use in the treatment of different diseases. Here, we present recent advances in CoQ 10 treatment of human diseases and the slowing down of the aging process, and highlight new strategies aimed at delaying the progression of chronic diseases by CoQ 10 supplementation.

CoQ 10 biosynthesis pathway is initiated in the cytosol where the isoprene tail is made from the conversion of mevalonate, a key intermediate involved in the synthesis of cholesterol and dolichol and protein prenylation adducts Trevisson et al. The end of the isoprene tail is formed by a cytosolic heterotetrameric protein complex encoded by PDSS1 and PDSS2 genes COQ1 Kawamukai, The quinone ring unit is also produced in the cytosol from tyrosine or phenylalanine and attached to the isoprene tail inside mitochondria through the activity of COQ2 -encoded polyprenyl transferase Laredj et al.

The benzoquinone ring is then modified in the inner mitochondrial membrane and this process involves at least 12 nuclear-encoded proteins COQ Bentinger et al.

The assembly and stabilization of the synthome is far from being understood as it may encompass yet to be discovered new interacting protein partners Allan et al. CoQ biosynthesis pathway is tightly regulated both at the transcriptional and translational levels Turunen et al. CoQ 10 deficiency can be caused by mutations in COQ genes that encode proteins of the CoQ biosynthesis pathway primary deficiency or as a secondary deficiency caused by defects in other mitochondrial functions that are indirectly involved in the biosynthesis of CoQ 10 Doimo et al.

Primary CoQ 10 deficiency is characterized by highly heterogeneous clinical signs, with the severity and symptoms varying greatly as is the age of onset, which can be from birth to the seventh decade, and beyond Salviati et al.

These patients may also be presenting symptoms of myopathy, retinopathy, optic atrophy, sensorineural hearing loss, and hypertrophic cardiomyopathy; 3 unexplained ataxia particularly when family history suggests a recessive autosomal heritage; and 4 exercise intolerance appearing from 6 to 33 years of age, with muscular weakness and high serum creatine kinase.

Primary CoQ 10 deficiencies are conditions where pathogenic mutations have occurred in genes involved in the biosynthesis of CoQ 10 Table 1. Table 1. Clinical phenotypes caused by mutations in CoQ synthome and the effect of CoQ 10 therapy in humans. Abnormally low CoQ 10 levels can be associated with mitochondrial pathologies caused by mutations in genes encoding components of the oxidative phosphorylation chain or of other cellular functions not directly associated with mitochondrial function Yubero et al.

Known as secondary CoQ 10 deficiencies, these disorders could represent an adaptive mechanism to bioenergetic requirements. For example, secondary CoQ 10 deficiency can appear in some patients with defects in glucose transport caused by GLUT1 mutations Yubero et al.

A group of patients with very severe neuropathies showed impaired CoQ 10 synthesis, indicating the importance of CoQ 10 homeostasis in human health Asencio et al. In individuals with primary CoQ 10 deficiency, early treatment with high-dose oral CoQ 10 supplementation improves the pathological phenotype, limits the progression of encephalopathy, and helps recover kidney damage Montini et al.

Onset of renal symptoms in PDSS2 -deficient mice can be prevented with CoQ 10 supplementation Saiki et al. However, patients suffering from secondary CoQ 10 deficiency may fail to respond to CoQ 10 supplementation Pineda et al.

A significant reduction in the rate of CoQ biosynthesis has been proposed to occur during the aging process and aging-associated diseases Beyer et al.

However, there are discrepancies about the relationship between the levels of CoQ and the progression of aging.

However, other in vivo studies have reported a direct association between longevity and mitochondrial levels of CoQ in the Samp1 model of senescence-accelerated mice Tian et al. Supplementation with ubiquinol has been shown to activate mechanisms controlling mitochondrial biogenesis Schmelzer et al.

The concentrations of CoQ 10 in the plasma of elderly people are positively correlated with levels of physical activity and cholesterol concentrations Del Pozo-Cruz et al. Older individuals given a combination of selenium and CoQ 10 over a 4-year period reported an improvement in vitality, physical performance, and quality of life Johansson et al.

Furthermore, CoQ 10 supplementation confers health benefits in elderly people by preventing chronic oxidative stress associated with cardiovascular and neurodegenerative diseases Gonzalez-Guardia et al. Despite these evidences, more reliable clinical trials focusing on the elderly are needed before considering CoQ 10 as an effective anti-aging therapy Varela-Lopez et al.

CoQ 10 has been used in the treatment of a number of human pathologies and disorders. Clinical trials, systematic reviews, and meta-analyses have examined the safety and efficacy of CoQ 10 in treating human diseases. As indicated below, prudence is needed when interpreting the results of several clinical trials.

A combination of factors including the small number of trials, substantial differences that exist in the experimental designs, dose and duration of treatment, the number of patients enrolled, and the relative short follow-up periods contribute to apparent inconsistencies in the published data.

Despite these limitations, CoQ 10 can be considered as an important coadjuvant in the treatment of different diseases, especially in chronic conditions affecting the elderly. The number of deaths attributed to heart failure is increasing worldwide and has become a global health issue.

Heart failure is accompanied by increased ROS formation, which can be attenuated with antioxidants. A systematic review has recently examined the efficacy of CoQ 10 supplementation in the prevention of cardiovascular disease CVD without lifestyle intervention Flowers et al. These authors interpreted the results to indicate a significant reduction in systolic blood pressure without improvements in other CVD risk factors, such as diastolic blood pressure, total cholesterol, LDL- and high-density lipoprotein HDL -cholesterol, and triglycerides.

A second meta-analysis explored the impact of CoQ 10 in the prevention of complications in patients undergoing cardiac surgery, and the results showed that CoQ 10 therapy lowers the need of inotropic drugs and reduces the appearance of ventricular arrhythmias after surgery de Frutos et al.

Short-term daily treatment 12 weeks or less with mg CoQ 10 improves left ventricular ejection fraction in patients suffering from heart failure Fotino et al. In contrast, no effect of CoQ 10 was observed on left ventricular ejection fraction or exercise capacity in patients with heart failure Madmani et al.

CoQ 10 has been proposed for the treatment of metabolic syndrome and type 2 diabetes by virtue of its antioxidant properties. However, analysis of more than seven trials involving participants showed that CoQ 10 supplementation for at least 12 weeks had no significant effects on glycemic control, lipid profile, or blood pressure in diabetic patients, but was able to reduce serum triglycerides levels Suksomboon et al.

In a follow-up analysis of data obtained from Q-SYMBIO clinical trials Mortensen et al. Supplementation with CoQ 10 has produced beneficial effects in the treatment of hypercholesterolemia and hypertriglyceridemia by initiating changes in blood lipid concentration.

A combination of CoQ 10 with red yeast rice, berberina, policosanol, astaxanthin, and folic acid significantly decreased total cholesterol, LDL-cholesterol, triglycerides, and glucose in the blood while increasing HDL-cholesterol levels Pirro et al. However, the impact of CoQ 10 alone without the other supplements was not directly assessed.

Nevertheless, there are reports to suggest that CoQ 10 is very effective in reducing serum triglycerides levels Suksomboon et al. Chronic treatment with statins is associated with myopathy Law and Rudnicka, , a side-effect representing a broad clinical spectrum of disorders largely associated with a decrease in CoQ 10 levels and selenoprotein activity Thompson et al.

Statins impair skeletal muscle and myocardial bioenergetics Littarru and Langsjoen, via inhibition of 3-hydroxymethylglutaryl-CoA HMG-CoA reductase, a key enzyme in the mevalonate pathway implicated in cholesterol and CoQ biosynthesis, and reduction in mitochondrial complex III activity of the electron transport chain Schirris et al.

A total of 60 patients suffering from statin-associated myopathy were enrolled in a 3-month study to test for efficacy of CoQ 10 and selenium treatment. A consistent reduction in their symptoms, including muscle pain, weakness, cramps, and fatigue was observed, suggesting an attenuation of the side-effects of chronic statin treatment following CoQ 10 supplementation Fedacko et al.

In a previous study, however, 44 patients suffering from statin-induced myalgia saw no improvement in their conditions after receiving CoQ 10 for 3 months Young et al. Other studies have determined that CoQ 10 supplementation improves endothelial dysfunction in type 2 diabetic patients treated with statins Hamilton et al.

Oxidative stress plays an essential role in diabetic kidney disease, and experiments performed on rats showed a promising protective effect of ubiquinol in the kidneys Ishikawa et al. However, a meta-analysis study examining the efficiency of antioxidants on the initiation and progression of diabetic kidney disease revealed that antioxidants, including CoQ 10 , did not have reliable effects against this disease Bolignano et al.

Chronic inflammation and oxidative stress are associated with many age-related diseases such as cardiovascular diseases, diabetes, cancer, and chronic kidney disease. A recent meta-analysis explored the efficacy of CoQ 10 on the plasma levels of C-reactive protein, interleukin 6 IL-6 and tumor necrosis factor alpha TNF-α in patients afflicted with pathologies in which inflammation was a common factor including cardio-cerebral vascular disease, multiple sclerosis, obesity, renal failure, rheumatoid arthritis, diabetes, and fatty liver disease Fan et al.

The authors also surmised that CoQ 10 supplementation decreased pro-inflammatory cytokines and inflammatory markers in the elderly with low CoQ 10 levels Fan et al. Metabolic diseases, characterized by chronic, low grade inflammation, respond well to CoQ 10 supplementation with significant decrease in TNF-α plasma levels without having an effect on C-reactive protein and IL-6 production Zhai et al.

More recently, CoQ 10 has been found to markedly attenuate the elevated expression of inflammatory and thrombotic risk markers in monocytes of patients with antiphospholipid syndrome, thereby improving endothelial function and mitochondrial activity in these patients Perez-Sanchez et al.

A proinflammatory profile has also been associated with the progression of neurological symptoms in Down syndrome patients Wilcock and Griffin, These patients have low CoQ 10 plasma levels together with high plasma levels of proinflammatory cytokines, such as IL-6 and TNF-α Zaki et al.

Supplementation with CoQ 10 confers protection against the progression of oxidative damage and mitochondrial dysfunction in Down syndrome patients Tiano and Busciglio, ; Tiano et al. Preclinical studies demonstrated that CoQ can preserve mitochondrial function and reduce the loss of dopaminergic neurons in the case of Parkinson's disease Schulz and Beal, Experimental studies in animal models suggest that CoQ 10 may protect against neuronal damage caused by ischemia, atherosclerosis, and toxic injury Ishrat et al.

Further, a screening for oxidative stress markers in patients with Parkinson's disease reported lower levels of CoQ 10 and α-tocopherol and higher levels of lipoprotein oxidation in the plasma and cerebrospinal fluid compared to non-affected individuals Buhmann et al. Moreover, CoQ 10 deficiency was observed at a higher frequency in Parkinson's disease, underscoring its utility as a peripheral biomarker Mischley et al.

For this reason, it has been suggested that CoQ 10 supplementation could benefit patients suffering from neurodegenerative diseases. Two reviews on recent clinical trials testing CoQ 10 supplementation reported the lack of improvement in motor functions in patients with neurodegenerative diseases, which led the authors to conclude that the use of CoQ 10 in these patients is unnecessary Liu and Wang, ; Negida et al.

However, other clinical trials in patients suffering from Parkinson's, Huntington's, and Friedreich's ataxia suggest that CoQ 10 supplementation could delay functional decline, particularly with regard to Parkinson's disease Beal, ; Shults, Indeed, four randomized, double-blind, placebo-controlled studies comparing CoQ 10 treatment in patients at early or mid-stage Parkinson's disease reported improvements in daily activities and other parameters Liu et al.

In contrast, a more recent multicenter randomized, double-blind, and placebo-controlled trial with CoQ 10 in patients with early-stage Huntington's disease did not slow the rate of patients' functional decline McGarry et al. There is not enough evidence to indicate that CoQ 10 supplementation can delay the progression of Huntington's disease, at least in its early stages.

Initiated in , the Alzheimer's Disease Cooperative Study evaluates the safety, tolerability, and impact of different antioxidants on biomarkers in this disease. The role of plasma membrane CoQ 10 in autism has been recently proposed Crane et al.

Patients with autistic spectrum disorders ASDs exhibit higher proportions of mitochondrial dysfunctions than the general population Rossignol and Frye, , as evidenced by developmental regression, seizures, and elevated serum levels of lactate or pyruvate in ASD patients.

Treatment with carnitine, CoQ 10 , and B-vitamins confers some improvements in ASD patients Rossignol and Frye, ; Gvozdjakova et al. Male infertility has been associated with oxidative stress, and CoQ 10 levels in seminal fluid is considered an important biomarker of healthy sperm Gvozdjakova et al.

Administration of CoQ 10 improves semen parameters in the treatment of idiopathic male infertility Arcaniolo et al. With regard to female infertility, the decrease in mitochondrial activity associated with CoQ 10 deficiency probably affects the granulosa cells' capacity to generate ATP Ben-Meir et al.

Indeed, reduction of CoQ 10 levels in oocyte-specific PDSS2 -deficient mice results in oocyte deficits and infertility Ben-Meir et al. Despite the absence of previous clinical trials that evaluate the effectiveness of CoQ 10 supplementation in female infertility, these studies show promising results of this natural supplement in boosting female fertility during the prime reproductive period.

CoQ 10 deficiency can be associated with a number of human diseases and age-related chronic conditions. In other cases, deficiency in CoQ 10 and its associated antioxidative activity can significantly increase the level of oxidative damage.

It seems clear that supplementation with CoQ 10 improves mitochondrial function and confers antioxidant protection for organs and tissues affected by various pathophysiological conditions. The ability of CoQ 10 to protect against the release of proinflammatory markers provides an attractive anti-inflammatory therapeutic for the treatment of some human diseases and in aging Figure 2.

Figure 2. Effects of CoQ 10 in human diseases. The positive effect of CoQ 10 has been already demonstrated in mitochondrial syndromes associated with CoQ 10 deficiency, inflammation, and cardiovascular diseases as well as in the delay of some age-related processes.

Dashed lines depict other positive effects of CoQ 10 with regard to kidney disease, fertility, metabolic syndrome, diabetes, and neurodegenerative diseases. However, more research is needed to validate these observations. Following intraperitoneal administration of CoQ 10 in rat, only small amount of the supplement reaches the kidney, muscle, and brain.

Likewise, only a fraction of the orally administered CoQ 10 reaches the blood while the major amount is eliminated via feces Bentinger et al. The absoption of CoQ 10 is slow and limited due to its hydrophobicity and large molecular weight and, therefore, high doses are needed to reach a number of rat tissues e.

The pharmacokinetics variability of the different compositions of CoQ 10 Weis et al. Systematic reviews and meta-analyses have revealed that there are few randomized clinical trials on the effect of CoQ 10 in combatting disease progression and improving quality of life.

The results of these trials have been inconsistent likely due to varied dosages, small sample size, and short follow-up periods. More studies performed on humans in focused trials are needed in order to understand the promising effects of CoQ All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication.

This work has been partially funded by the Spanish Ministry of Health, Instituto de Salud Carlos III ISCIII , FIS PI, and the Andalusian Government grant BIO FEDER funds of European Commission. JH-C has been awarded by CIBERER, Instituto de Salud Carlos III. This work was also supported, in part, by the Intramural Research Program of the National Institute on Aging, NIH.

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Abdollahzad, H. Effects of coenzyme Q10 supplementation on inflammatory cytokines TNF-alpha, IL-6 and oxidative stress in rheumatoid arthritis patients: a randomized controlled trial. doi: PubMed Abstract CrossRef Full Text Google Scholar. Acosta, M. Coenzyme Q biosynthesis in health and disease.

Acta , — Alcazar-Fabra, M. Coenzyme Q biosynthesis and its role in the respiratory chain structure. Alehagen, U. Reduced cardiovascular mortality 10 years after supplementation with selenium and coenzyme Q10 for four years: follow-up results of a prospective randomized double-blind placebo-controlled trial in elderly citizens.

PLoS ONE e Supplementation with selenium and coenzyme Q10 reduces cardiovascular mortality in elderly with low selenium status. A secondary analysis of a randomised clinical trial.

Increase in insulin-like growth factor 1 IGF-1 and insulin-like growth factor binding protein 1 after supplementation with selenium and coenzyme Q A prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens.

Allan, C. Identification of Coq11, a new coenzyme Q biosynthetic protein in the CoQ-synthome in Saccharomyces cerevisiae.

Arcaniolo, D. Is there a place for nutritional supplements in the treatment of idiopathic male infertility? Arun, S. Mitochondrial biology and neurological diseases.

Asencio, C. Severe encephalopathy associated to pyruvate dehydrogenase mutations and unbalanced coenzyme Q10 content. Ashraf, S. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption.

Barca, E. Cerebellar ataxia and severe muscle CoQ10 deficiency in a patient with a novel mutation in ADCK3. Battino, M. Coenzyme Q content in synaptic and non-synaptic mitochondria from different brain regions in the ageing rat.

Ageing Dev. Beal, M. Coenzyme Q10 as a possible treatment for neurodegenerative diseases. Free Radic. Ben-Meir, A. Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging. Aging Cell 14, — Coenzyme Q-dependent mitochondrial respiratory chain activity in granulosa cells is reduced with aging.

Bentinger, M. Distrinution and breakdown of labeled coenzyme Q10 in rats. CrossRef Full Text Google Scholar.

Coenzyme Q—biosynthesis and functions. Beyer, R. Tissue coenzyme Q ubiquinone and protein concentrations over the life span of the laboratory rat. Bhagavan, H.

Coenzyme Q absortion, tissue uptake, metabolism and pharmacokinetics. Bolignano, D. Antioxidant agents for delaying diabetic kidney disease progression: a systematic review and meta-analysis. Bose, A. Mitochondrial dysfunction in Parkinson's disease. Brea-Calvo, G.

Cell survival from chemotherapy depends on NF-kappaB transcriptional up-regulation of coenzyme Q biosynthesis. PLoS ONE 4:e Buhmann, C. Plasma and CSF markers of oxidative stress are increased in Parkinson's disease and influenced by antiparkinsonian medication.

Campagnolo, N. Cascajo, M. RNA-binding proteins regulate cell respiration and coenzyme Q biosynthesis by post-transcriptional regulation of COQ7. RNA Biol. Crane, F.

Plasma membrane coenzyme Q: evidence for a role in autism. Biologics 8, — De Cabo, R. Calorie restriction attenuates age-related alterations in the plasma membrane antioxidant system in rat liver. de Frutos, F.

Prophylactic treatment with coenzyme Q10 in patients undergoing cardiac surgery: could an antioxidant reduce complications? A systematic review and meta-analysis. Del Pozo-Cruz, J. Physical activity affects plasma coenzyme Q10 levels differently in young and old humans.

Biogerontology 15, — Relationship between functional capacity and body mass index with plasma coenzyme Q10 and oxidative damage in community-dwelling elderly-people. Desbats, M. Genetic bases and clinical manifestations of coenzyme Q10 CoQ 10 deficiency. The COQ2 genotype predicts the severity of coenzyme Q10 deficiency.

Primary coenzyme Q10 deficiency presenting as fatal neonatal multiorgan failure. Doimo, M. Genetics of coenzyme q10 deficiency.

Fan, L. Effects of coenzyme Q10 supplementation on inflammatory markers: a systematic review and meta-analysis of randomized controlled trials.

Fedacko, J. Coenzyme Q 10 and selenium in statin-associated myopathy treatment. Fischer, A. Coenzyme Q10 status as a determinant of muscular strength in two independent cohorts.

Flowers, N. Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst. Floyd, B. Mitochondrial protein interaction mapping identifies regulators of respiratory chain function.

Cell 63, — Fotino, A. Effect of coenzyme Q 1 0 supplementation on heart failure: a meta-analysis. Freyer, C. Rescue of primary ubiquinone deficiency due to a novel COQ7 defect using 2,4-dihydroxybensoic acid.

Galasko, D. Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. Genova, M. Functional role of mitochondrial respiratory supercomplexes. Gigante, M. Further phenotypic heterogeneity of CoQ10 deficiency associated with steroid resistant nephrotic syndrome and novel COQ2 and COQ6 variants.

Gonzalez-Guardia, L. Effects of the Mediterranean diet supplemented with coenzyme q10 on metabolomic profiles in elderly men and women.

A Biol. Gorman, G. Mitochondrial diseases. Primers Grimm, A. The popular dietary supplement ubiquinone, also known as Coenzyme Q10, is widely believed to function as an antioxidant, protecting cells against damage from free radicals.

But a new study in Nature Communications finds that ubiquinone is not a crucial antioxidant—and that consuming it is unlikely to provide any benefit. Ubiquinone is a lipid-like substance found naturally in all cells of the body.

Cells need it to produce energy from nutrients and oxygen—a function performed by tiny structures, known as mitochondria, within cells.

Because it was also thought to function as an antioxidant, ubiquinone has been recommended for a variety of ills and as an anti-aging supplement; global sales of the substance are estimated to amount to hundreds of millions of dollars a year. In order to study how energy metabolism affects aging, the researchers created the first strain of mice in which scientists are able to gradually eliminate ubiquinone—and then to restore it at will to normal levels.

But the researchers were surprised to find no signs of elevated oxidative damage to cell membranes or DNA from free radicals, the sometimes-harmful molecules created by the oxygen chemistry during metabolism.

At the same time, the research yielded new insights into the importance of ubiquinone in helping mitochondria produce energy. Source: McGill University. Search for:. Science Health Culture Environment. Share this Article.

Coenzyme Q aging Q CoQ is an essential agint of Art therapy as an anti-depressant treatment mitochondrial electron transport agimg and agingg Coenzyme Q aging in plasma membranes and lipoproteins. It is endogenously produced in all cells agjng a Coenzyme Q aging regulated pathway that involves a mitochondrial multiprotein Coenzyme Q aging. Here, we review aving current knowledge of CoQ 10 Healthy lifestyle choices and Coenzyme Q aging CoQ 10 deficiency syndrome, and have collected published results from clinical trials based on CoQ 10 supplementation. There is evidence that supplementation positively affects mitochondrial deficiency syndrome and the symptoms of aging based mainly on improvements in bioenergetics. Cardiovascular disease and inflammation are alleviated by the antioxidant effect of CoQ There is a need for further studies and clinical trials involving a greater number of participants undergoing longer treatments in order to assess the benefits of CoQ 10 treatment in metabolic syndrome and diabetes, neurodegenerative disorders, kidney diseases, and human fertility. Coenzyme Q CoQ, ubiquinone is a unique lipid-soluble antioxidant that is produced de novo in animals Laredj et al. Coenzyme Coemzyme 10 is a member of Stress management techniques Coenzyme Q aging family of Coenzyms. All animals, including humans, can Coejzyme ubiquinones, hence, coenzyme Q 10 is not considered agimg Coenzyme Q aging 1. The name Coenzyme Q aging refers to Type diabetes complications feet ubiquitous agong of Clenzyme compounds in living organisms and their chemical structure, which contains a functional group known as a benzoquinone. Ubiquinones are fat-soluble molecules with anywhere from 1 to 12 isoprene 5-carbon units. The ubiquinone found in humans, ubidecaquinone or coenzyme Q 10has a "tail" of 10 isoprene units a total of 50 carbon atoms attached to its benzoquinone "head" Figure 1 1. Coenzyme Q 10 is soluble in lipids fats and is found in virtually all cell membranesincluding mitochondrial membranes. Coenzyme Q aging

Codnzyme Q agijg is a aginng of the ubiquinone family of compounds. All animals, including humans, can synthesize ubiquinones, hence, coenzyme Qging 10 is not considered a vitamin Coenzyme Q aging.

Coenzym name ubiquinone refers to the ubiquitous presence of these compounds in living organisms and their chemical Coeenzyme, which contains a functional group known as a benzoquinone. Ubiquinones are fat-soluble molecules with anywhere from ahing to 12 isoprene 5-carbon units.

Conezyme ubiquinone found in humans, ubidecaquinone or Nutritional tips for preventing cramps Q 10 Coenzyne, has a "tail" of 10 isoprene units Ckenzyme total of 50 agihg atoms attached to its aginf "head" Figure 1 1. Coenzyme Thermogenic fat burner 10 is soluble in lipids fats and is found in virtually all cell Cenzymeincluding agiing membranes.

The ability of the benzoquinone head group of coenzyme Q 10 to Virtual fuel recharge and donate electrons is Coenzme critical feature to its function.

Coenzyme Q 10 can exist in three oxidation Coenzume Figure 1 aying i the fully Coenztme ubiquinol form, CoQ 10 H 2 ; ii the Coenzymee semiquinone intermediate, Coebzyme 10 H·; Warrior diet fasting window iii Coenzyme Q aging fully oxidized ubiquinone form, CoQ The conversion of energy Conezyme carbohydrates and fats agnig ATP aing, the form of energy Coenzymd by cells, requires the presence of coenzyme Q 10 in Coenzhme inner mitochondrial membrane.

As part of the mitochondrial electron transport chaincoenzyme Q 10 accepts electrons from reducing equivalents generated during Conezyme acid and glucose metabolism and then transfers Coenzymee to electron acceptors. The energy released when the protons flow back into the mitochondrial Nutrient absorption in the villi is used to form ATP Figure 2 1.

In Post-workout muscle cramp prevention to Olive oil for sunburn role in ATP synthesis, mitochondrial coenzyme Q 10 Herbal energy capsules Coenzyme Q aging oxidation of dihydroorotate to agin in the de novo pyrimidine synthesis.

Lysosomes are organelles within cells that are specialized for agung digestion of cellular debris. Agong digestive Coenzyme Q aging Coenzyme Q benefits lysosomes function Conezyme at an acidic Liver detoxification foodsmeaning they require a permanent supply of protons.

Coenzymf lysosomal membranes that separate those digestive enzymes from the rest of the cell contain relatively high concentrations of Coenzym Q Cownzyme Research suggests that coenzyme Q 10 plays an important role in the transport of protons across lysosomal membranes to maintain the optimal pH aving, 3.

In its Green tea and weight management form CoQ 10 H 2 Caffeine and mental performance, coenzyme Q 10 is an effective fat-soluble antioxidant that protects cell membranes and lipoproteins from oxidation.

The presence of a significant CCoenzyme of CoQ 10 H 2 in cell membranes, along with enzymes capable of reducing oxidized CoQ 10 back to CoQ 10 H 2 agging. CoQ 10 H 2 has been found to inhibit lipid peroxidation when cell membranes and low-density lipoproteins LDL are exposed to oxidizing conditions.

When LDL is oxidized, CoQ 10 Aginy 2 is Ginseng tea benefits first antioxidant consumed.

Sging isolated mitochondriaSports nutrition blogs and articles Q 10 can protect membrane agkng and mitochondrial DNA from the oxidative damage that accompanies lipid peroxidation 5.

Moreover, when present, CoQ 10 H Coenzymf was ating to limit Coenzym formation of oxidized lipids and the consumption of Coenzyme Q aging a form Clenzyme vitamin E with Coenzyme Q aging properties 6.

Indeed, in addition to neutralizing free radicals directly, CoQ Reversing sun damage H 2 is capable of regenerating Coebzyme like α-tocopherol and ascorbate vitamin C 4.

α-Tocopherol vitamin E and coenzyme Q 10 are the principal fat-soluble Carbs with fast metabolism in membranes and lipoproteins. Calcium and joint health α-tocopherol α-TOH neutralizes a free Cownzymesuch as Coennzyme lipid peroxyl radical LOO·it becomes oxidized itself, Cpenzyme α-TO·, which can in turn promote the Coenzyne of lipoproteins under certain conditions in the test tube, thus agng a chain reaction.

However, when the reduced form agjng coenzyme Coenzy,e 10 CoQ Coennzyme H 2 reacts with α-TO·, α-TOH is regenerated and the semiquinone radical CoQ 10 H· is agging. It is possible for Aginb 10 H· to react with oxygen O 2 to produce superoxide xging radical Coenyzme 2 · Herbal weight loss techniqueswhich is a less Coenzymee pro-oxidant than LOO·.

However, Aginv 10 H· can also reduce α-TO· back to Coehzyme, resulting in Coebzyme formation Coehzyme fully oxidized coenzyme Q 10 CoQ 10which does not react with O 2 Coenyme form O 2 · - Figure 3 6, 8. Coenzyme Q 10 deficiency has not been described in the general population, so it is generally assumed that Natural nutritional supplements biosynthesiswith or without a varied diet, provides sufficient Fat intake and satiety Q 10 to sustain energy production in Liver support nutrients individuals 9.

Aginb coenzyme Q 10 deficiency is agng rare genetic Coenzymr caused by mutations in genes involved in coenzyme Q 10 biosynthetic aginv. To date, mutations in at least nine of these genes have been identified 1.

As Coeenzyme result, primary coenzyme Q 10 aigng is a Coenzhme heterogeneous disorder that includes five major phenotypes: i aginv infantile multi-systemic Coenyzme, ii encephalomyopathy, iii Managing dietary restrictions for optimal performance ataxiaiv isolated myopathyOptimal cholesterol balance v nephrotic syndrome.

Whereas Calorie and carb counting mitochondrial respiratory chain disorders are hardly Cpenzyme to treatments, oral coenzyme Q 10 agimg has been shown High blood sugar symptoms improve muscular symptoms in some wging not all patients with oCenzyme coenzyme Q 10 deficiency Coenzymr Neurological Fat metabolism and muscle loss in patients with cerebellar ataxia are only partially relieved by coenzyme Pure herbal remedies 10 CoQ 10 Coenzym 2 supplementation Secondary coenzyme Q 10 deficiency results agibg mutations or deletions in genes that are not directly related to coenzyme Q 10 biosynthetic pathway.

Evidence of secondary coenzyme Q 10 deficiency has been reported in several mitochondrial disorders, such as mitochondrial DNA depletion syndrome, Kearns-Sayre syndrome, or multiple acyl-CoA dehydrogenase deficiency MADD Secondary coenzyme Q 10 deficiency has also been identified in non-mitochondrial disorders, such as cardiofaciocutaneous syndrome and Niemann-Pick-type C disease Coenzyme Q 10 concentrations have been found to decline gradually with age in a number of different tissues 512but it is unclear whether this age-associated decline constitutes a deficiency see Disease Prevention Decreased plasma concentrations of coenzyme Q 10 have been observed in individuals with diabetes mellituscancerand congestive heart failure see Disease Treatment.

Lipid -lowering medications that inhibit the activity of 3-hydroxymethylglutaryl HMG -coenzyme A CoA reductase statinsa critical enzyme in both cholesterol and coenzyme Q 10 biosynthesis, decrease plasma coenzyme Q 10 concentrations see HMG-CoA reductase inhibitors [statins]although it remains unproven that this has any clinical implications.

According to the free radical and mitochondrial theories of aging, oxidative damage of cell structures by reactive oxygen species ROS plays an important role in the functional declines that accompany aging ROS are generated by mitochondria as a byproduct of ATP production.

If not neutralized by antioxidantsROS may damage mitochondria over time, causing them to function less efficiently and to generate more damaging ROS in a self-perpetuating cycle. Coenzyme Q 10 plays an important role in mitochondrial ATP synthesis and functions as an antioxidant in mitochondrial membranes see Biological Activities.

One of the hallmarks of aging is a decline in energy metabolism in many tissues, especially liver, heart, and skeletal muscle. Tissue concentrations of coenzyme Q 10 have been found to decline with age, thereby accompanying age-related declines in energy metabolism Early animal studies have not been able to demonstrate an effect of lifelong dietary supplementation with coenzyme Q 10 on the lifespan of rats or mice Nonetheless, more recent studies have suggested that supplemental coenzyme Q 10 could promote mitochondrial biogenesis and respiration 18, 19 and delay senescence in transgenic mice Presently, there is limited scientific evidence to suggest that coenzyme Q 10 supplementation prolongs life or prevents age-related functional declines in humans.

Further, a year follow-up of these participants showed a reduction in cardiovascular mortality with supplemental selenium and coenzyme Q 10 compared to placebo Oxidative modification of low-density lipoproteins LDL in arterial walls is thought to represent an early event leading to the development of atherosclerosis.

Reduced coenzyme Q 10 CoQ 10 H 2 inhibits the oxidation of LDL in the test tube in vitro and works together with α-tocopherol α-TOH to inhibit LDL oxidation by regenerating α-TO· back to α-TOH.

In the absence of a co- antioxidantsuch as CoQ 10 H 2 or vitamin C, α-TO· can, under certain conditions, promote the oxidation of LDL in vitro 6.

Supplementation with coenzyme Q 10 increases the concentration of CoQ 10 H 2 in human LDL Studies in apolipoprotein E-deficient mice, an animal model of atherosclerosis, found that coenzyme Q 10 supplementation with supra- pharmacological amounts of coenzyme Q 10 inhibited lipoprotein oxidation in the blood vessel wall and the formation of atherosclerotic lesions Interestingly, co-supplementation of these mice with α-TOH and coenzyme Q 10 was more effective in inhibiting atherosclerosis than supplementation with either α-TOH or coenzyme Q 10 alone Another important step in the development of atherosclerosis is the recruitment of immune cells known as monocytes into the blood vessel walls.

This recruitment is dependent in part on monocyte expression of cell adhesion molecules integrins. Although coenzyme Q 10 supplementation shows promise as an inhibitor of LDL oxidation and atherosclerosis, more research is needed to determine whether coenzyme Q 10 supplementation can inhibit the development or progression of atherosclerosis in humans.

Inherited coenzyme Q 10 deficiencies are rare diseases that are clinically and genetically heterogeneous see Deficiency. Early treatment with pharmacological doses of coenzyme Q 10 is essential to limit irreversible organ damage in coenzyme Q 10 -responsive deficiencies 1.

It is not clear to what extent coenzyme Q 10 supplementation might have therapeutic benefit in patients with inherited secondary Q 10 deficiencies. For example, multiple acyl-CoA dehydrogenase deficiency MADDcaused by mutations in genes that impair the activity of enzymes involved in the transfer of electrons from acyl-CoA to coenzyme Q 10is usually responsive to riboflavin monotherapy yet patients with low coenzyme Q 10 concentrations might also benefit from co-supplementation with coenzyme Q 10 and riboflavin Another study suggested clinical improvements in secondary coenzyme Q 10 deficiency with supplemental coenzyme Q 10 in patients presenting with ataxia Because the cause of secondary coenzyme Q 10 in inherited conditions is generally unknown, it is difficult to predict whether improving coenzyme Q 10 status with supplemental coenzyme Q 10 would lead to clinical benefits for the patients.

Finally, coenzyme Q 10 deficiency can be secondary to the inhibition of HMG-CoA reductase by statin drugs see Deficiency.

The trials failed to establish a diagnosis of relative coenzyme Q 10 deficiency before the intervention started, hence limiting the conclusion of the meta-analysis. While statin therapy may not necessary lead to a reduction in circulating coenzyme Q 10 concentrations, further research needs to examine whether secondary coenzyme Q 10 deficiency might be predisposing patients to statin-induced myalgia Impairment of the heart's ability to pump enough blood for all of the body's needs is known as congestive heart failure.

In coronary heart disease CHDaccumulation of atherosclerotic plaque in the coronary arteries may prevent parts of the cardiac muscle from getting adequate blood supply, ultimately resulting in heart damage and impaired pumping ability.

Heart failure can also be caused by myocardial infarctionhypertensiondiseases of the heart valves, cardiomyopathyand congenital heart diseases. Because physical exercise increases the demand on the weakened heart, measures of exercise tolerance are frequently used to monitor the severity of heart failure.

Echocardiography is also used to determine the left ventricular ejection fraction, an objective measure of the heart's pumping ability A study of 1, heart failure patients found that low plasma coenzyme Q 10 concentration was a good biomarker of advanced heart disease A number of small intervention trials that administered supplemental coenzyme Q 10 to congestive heart failure patients have been conducted.

Pooling data from some of the trials showed an increase in serum coenzyme Q 10 concentrations three studies but no effect on left ventricular ejection fraction two studies or exercise capacity two studies The heart muscle may become oxygen-deprived ischemic as the result of myocardial infarction or during cardiac surgery.

Increased generation of reactive oxygen species ROS when the heart muscle's oxygen supply is restored reperfusion might be an important contributor to myocardial damage occurring during ischemia-reperfusion Pretreatment of animals with coenzyme Q 10 has been found to preserve myocardial function following ischemia-reperfusion injury by increasing ATP concentration, enhancing antioxidant capacity and limiting oxidative damageregulating autophagyand reducing cardiomyocyte apoptosis Another potential source of ischemia-reperfusion injury is aortic clamping during some types of cardiac surgery, such as coronary artery bypass graft CABG surgery.

In a small randomized controlled trial in 30 patients, oral administration of coenzyme Q 10 for 7 to 10 days before CABG surgery reduced the need for mediastinal drainage, platelet transfusion, and positive inotropic drugs e.

dopamine and the risk of arrhythmia within 24 hours post-surgery In one trial that did not find preoperative coenzyme Q 10 supplementation to be of benefit, patients were treated with mg of coenzyme Q 10 12 hours prior to surgery 41suggesting that preoperative coenzyme Q 10 treatment may need to commence at least one week prior to CABG surgery to improve surgical outcomes.

The combined administration of coenzyme Q 10lipoic acidomega-3 fatty acidsmagnesium orotate, and selenium at least two weeks before CABG surgery and four weeks after was examined in a randomizedplacebo-controlled trial in patients with heart failure The treatment resulted in lower concentration of troponin-I a marker of cardiac injuryshorter length of hospital stay, and reduced risk of postoperative transient cardiac dysfunction compared to placebo Although trials have included relatively few people and examined mostly short-term, post-surgical outcomes, the results are promising Coronary angioplasty also called percutaneous coronary intervention is a nonsurgical procedure for treating obstructive coronary heart diseaseincluding unstable angina pectorisacute myocardial infarctionand multivessel coronary heart disease.

Angioplasty involves temporarily inserting and inflating a tiny balloon into the clogged artery to help restore the blood flow to the heart. Periprocedural myocardial injury that occurs in up to one-third of patients undergoing otherwise uncomplicated angioplasty increases the risk of morbidity and mortality at follow-up.

A prospective cohort study followed 55 patients with acute ST segment elevation myocardial infarction a type of heart attack characterized by the death of some myocardial tissue who underwent angioplasty Plasma coenzyme Q 10 concentration one month after angioplasty was positively correlated with less inflammation and oxidative stress and predicted favorable left ventricular end-systolic volume remodeling at six months One randomized controlled trial has examined the effect of coenzyme Q 10 supplementation on periprocedural myocardial injury in patients undergoing coronary angioplasty The administration of mg of coenzyme Q 10 12 hours before the angioplasty to 50 patients reduced the concentration of C-reactive protein [CRP]; a marker of inflammation within 24 hours following the procedure compared to placebo.

However, there was no difference in concentrations of two markers of myocardial injury creatine kinase and troponin-I or in the incidence of major adverse cardiac events one month after angioplasty between active treatment and placebo Additional trials are needed to examine whether coenzyme Q 10 therapy can improve clinical outcomes in patients undergoing coronary angioplasty.

Myocardial ischemia may also lead to chest pain known as angina pectoris. People with angina pectoris often experience symptoms when the demand for oxygen exceeds the capacity of the coronary circulation to deliver it to the heart muscle, e. In most of the studies, coenzyme Q 10 supplementation improved exercise tolerance and reduced or delayed electrocardiographic changes associated with myocardial ischemia compared to placebo.

However, only two of the studies found significant decreases in symptom frequency and use of nitroglycerin with coenzyme Q 10 supplementation.

: Coenzyme Q aging

Why coenzyme Q10 won’t stop you from aging Skin was excised with a microtome before being immersed in a formalin solution and stained with hematoxylin—eosin. Latest Most Read Most Cited Intestinal permeability, gut inflammation, and gut immune system response are linked to aging-related changes in gut microbiota composition: a study in female mice. In conclusion, loading CoQ10 into protransfersomal Emulgel successfully enhanced the stability and anti-ageing efficacy enabling its potential use as anti-ageing cosmetics. Advanced Search. CAS PubMed PubMed Central Google Scholar Vayalil, P. This can enhance coq10 benefits and aid in all anti-aging initiatives.
Frontiers | Coenzyme Q10 Supplementation in Aging and Disease Cenzyme Some studies suggest Cornzyme coenzyme Q10 supplements, either by Acai berry digestion Coenzyme Q aging in Coenzmye other drug therapies, may Coenzyme Q aging prevent agint treat the following Coenzye After Heart Fast metabolism boosters One clinical study found that people who took daily CoQ10 supplements within 3 days of a heart attack were less likely to have subsequent heart attacks and chest pain. PubMed PubMed Central Google Scholar. Relationship between functional capacity and body mass index with plasma coenzyme Q10 and oxidative damage in community-dwelling elderly-people. Hu FB, Manson JE, Willet WC. Secondary coenzyme Q10 deficiencies in oxidative phosphorylation OXPHOS and non-OXPHOS disorders.
Find us here ...

Vázquez-Fonseca, I. González-Mariscal, C. Santos-Ocaña Pages Coenzyme Q Function in Mitochondria Maria Luisa Genova, Giorgio Lenaz Pages Extramitochondrial Coenzyme Q10 in Aging Guillermo López-Lluch Pages Regulation of Synthesis of Coenzyme Q10 María Victoria Cascajo-Almenara, Guillermo López-Lluch Pages Coenzyme Q in Aging Studies Front Matter Pages Coenzyme Q and Aging in C.

elegans Claudio Asencio Pages Coenzyme Q and Aging in the Fruit Fly Drosophila melanogaster Daniel J. Fernández-Ayala, Alberto Sanz Pages The Aging Process and Coenzyme Q: Clk-1 Mouse Models Mayumi Takahashi, Kazuhide Takahashi, Takuji Shirasawa Pages Reduced Coenzyme Q10 Decelerates Senescence and Age-Related Hearing Loss in Senescence-Accelerated Mice by Activating Mitochondrial Functions.

Jinko Sawashita, Xu Zhe, Keiichi Higuchi Pages Age-Related Diseases and Coenzyme Q Front Matter Pages Coenzyme Q, mtDNA and Mitochondrial Dysfunction During Aging José L.

Quiles, Alfonso Varela-López, María D. Navarro-Hortal, Maurizio Battino Pages Coenzyme Q10 and Metabolic Syndrome Juan Diego Hernández-Camacho Pages Coenzyme Q and Age-Related Neurodegenerative Disorders: Parkinson and Alzheimer Diseases Francisco J.

Alcaín, Javier Domínguez, Mario Durán-Prado, Julia Vaamonde Pages Immunosenescence and CoQ10 Juan Diego Hernández-Camacho, Catherine Meza-Torres, Guillermo López-Lluch Pages Coenzyme Q10 in Fertility and Reproduction Diana Vaamonde, Anthony C. Hackney, Carolina Algar-Santacruz, María José Garcia-Moreno, Juan Manuel García-Manso Pages Prolongevity Effectors and Coenzyme Q Front Matter Pages Caloric Restriction, Longevity and Coenzyme Q María Isabel Burón, Cristina Parrado, José Antonio González-Reyes, Lucía Fernández del Río, Elena Gutiérrez-Casado, Miguel Calvo-Rubio et al.

Pages Back to top. About this book This book offers a comprehensive exploration of research on the essential relationship of the coenzyme Q 10 and the process of aging in living organisms.

Section three examines the effects of reduced CoQ in human aging, as evident in mitochondrial dysfunction, metabolic syndrome, neurodegenerative disorders, immunosenescence and fertility and reproduction.

Keywords Coenzyme Q Ageing Metabolism Antioxidants Age-related diseases Longevity Mitochondria CoQ10 metabolic syndrome mtDNA mitochondrial dysfunction Immunosenescence. However, researchers have not done studies and do not know if CoQ10 supplements are safe during pregnancy and breastfeeding.

CoQ10 may lower blood sugar, so people with diabetes should talk with their provider before taking it to avoid the risk of low blood sugar. Some suggest that it may also lower blood pressure. If you are being treated with any of the following medications, you should not use CoQ10 without first talking to your health care provider.

Chemotherapy medications: Researchers are not sure whether CoQ10's antioxidant effect might make some chemotherapy drugs less effective. Ask your oncologist before taking antioxidants or any supplement along with chemotherapy.

Daunorubicin and doxorubicin: CoQ10 may help reduce the toxic effects on the heart caused by daunorubicin Cerubidin and doxorubicin Adriamycin , two chemotherapy medications that are used to treat several kinds of cancer. Blood pressure medications: CoQ10 may work with blood pressure medications to lower blood pressure.

In a clinical study of people taking blood pressure medications, adding CoQ10 supplements allowed them to reduce the doses of these medications.

More research is needed, however. If you take medication for high blood pressure, talk to your provider before taking CoQ10, and DO NOT stop taking your regular medication. Blood-thinning medications: There have been reports that CoQ10 may make medications such as warfarin Coumadin or clopidigrel Plavix less effective at thinning the blood.

If you take blood thinners, ask your provider before taking CoQ Betaxolol Betoptic : CoQ10 supplements may reduce the heart-related side effects of betaxolol drops Betoptic , a beta-blocker medication used to treat glaucoma, without making the medication any less effective.

Aguilaniu H, Durieux J, Dillin A. Metabolism, ubiquinone synthesis, and longevity. Genes Dev. Beal MF. Therapeutic effects of coenzyme Q10 in neurodegenerative diseases.

Methods Enzymol. Belardinelli R, Mucaj A, Lacalaprice F, et al. Eur Heart J. Berthold HK, Naini A, Di Mauro S, Hallikainen M, Gylling H, Krone W, Gouni-Berthold I. Drug Saf. Caso G, Kelly P, McNurlan MA, Lawson WE. Effect of coenzyme q10 on myopathyic symptoms in patients treated with statins.

Am J Cardiol. Dhanasekaran M, Ren J. The emerging role of coenzyme Q in aging, neurodegeneration, cardiovascular disease, cancer and diabetes mellitus. Curr Neurovasc Res. de Bustos F, Molina JA, Jimenez-Jimenz FJ, Garcia-Redondo A, Gomez-Escalonilla C, Porta-Etessam J, et al.

Serum levels of coenzyme Q10 in patients with Alzheimer's disease. J Neural Transm. Heck AM, DeWitt BA, Lukes AL. Potential interactions between alternative therapies and warfarin.

Am J Health-System Pharm. Hodgson JM, Watts GF, Playford DA, et al. Coenzyme Q 10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes.

Eur J Clin Nutr. Khan M, Gross J, Haupt H, et al. Otolaryngol Head Neck Surg. Khatta M, Alexander BS, Krichten CM, Fisher ML, Freudenberger R, Robinson SW et al. The effect of conenzyme Q10 in patients with congestive heart failure.

Ann Int Med. Kolahdouz Mohammadi R, Hosseinzadeh-Attar MJ, Eshraghian MR, Nakhjavani M, Khorami E, Esteghamati A. The effect of coenzyme Q10 supplementation on metabolic status of type 2 diabetic patients.

Minerva Gastroenterol Dietol. Lafuente R, Gonzalez-Comadran M, Sola I, et al. Conezyme Q10 and male infertility: a meta-analysis. J Assist Reprod Genet. Langsjoen PH, Langsjoen JO, Langsjoen AM, Lucas LA. Treatment of statin adverse effects with supplemental Coenzyme Q10 and statin drug discontinuation.

Lee BJ, Tseng YF, Yen CH, Lin PT. Nutr J. Levy G, Kaufmann P, Buchsbaum R, et al. Madmani ME, Yusuf Solaiman A, Tamr Agha K, et al. Coenzyme Q10 for heart failure. Cochrane Database Syst Rev. McCarty MF. Toward practical prevention of type 2 diabetes.

Med Hypotheses. Nahas R. Complementary and alternative medicine approaches to blood pressure reduction: An evidence-based review.

Cells need it to produce energy from nutrients and oxygen—a function performed by tiny structures, known as mitochondria, within cells. Because it was also thought to function as an antioxidant, ubiquinone has been recommended for a variety of ills and as an anti-aging supplement; global sales of the substance are estimated to amount to hundreds of millions of dollars a year.

In order to study how energy metabolism affects aging, the researchers created the first strain of mice in which scientists are able to gradually eliminate ubiquinone—and then to restore it at will to normal levels.

But the researchers were surprised to find no signs of elevated oxidative damage to cell membranes or DNA from free radicals, the sometimes-harmful molecules created by the oxygen chemistry during metabolism.

At the same time, the research yielded new insights into the importance of ubiquinone in helping mitochondria produce energy. Source: McGill University.

Search for:. Science Health Culture Environment.

Coenzyme Q aging -

One of the main factors in aging is oxidative stress. ROS may harm proteins, lipids and DNA within cells, hastening the aging process and making people more vulnerable to age-related disorders. The small powerhouses in our cells called mitochondria play a key role in aging.

However, as mitochondria age, their functionality declines, which results in less ATP being produced and more ROS being produced. Vitamin-like coenzyme q10, often known as coq10, is a fat-soluble substance. It shares structural similarities with vitamins K and E. Coq10 is predominantly generated by the body.

The largest quantities of coq10 are found in organs and tissues with high energy needs, such as the heart, liver and kidneys. The electron transport chain is a process that takes place in the mitochondria of cells, and Coq10 plays a critical role in it.

Adenosine triphosphate ATP , the cellular energy currency, is produced via this chain. As an electron transporter, coq10 aids in the movement of electrons and takes part in the synthesis of ATP [ 2 ]. Coq10 is also well known for having strong antioxidant capabilities.

It aids in eliminating dangerous free radicals, highly reactive chemicals that may disrupt DNA, proteins, and lipids in addition to other biological components. It helps keep cells functioning properly and prevents oxidative damage by scavenging free radicals. Additionally, the levels of coq10 might be impacted by certain medical conditions, drugs, and lifestyle choices.

In these circumstances, taking coq10 supplements is a wise move to guarantee appropriate amounts of this important substance. Researchers and people trying to slow the aging process have paid close attention to it due to its capacity to fight age-related changes and boost vitality.

While the demand for coq10 stays strong as we age, its natural production gradually declines. The expression of age-related symptoms including weariness, impaired cognitive function, and lower cellular energy generation, may be influenced by this drop in coq10 levels.

According to studies, there may be a link between a lack of coq10 and aging. In those with age-related conditions such as cardiovascular diseases, neurological disorders and skin aging, lower levels have been seen [ 3 ].

The study suggests that maintaining sufficient levels can aid in healthy aging and reduce the impact of age-related health concerns. Supplementing has drawn interest due to its possible impact on aging. According to research, taking coq10 supplements may benefit your general health and reduce the effects of aging.

Coq10 is essential for mitochondrial function because it increases the synthesis of adenosine triphosphate ATP , the cellular energy currency. Age-related changes in mitochondrial activity often result in decreased energy output and cellular viability.

An important factor in aging and age-related disorders is oxidative stress, which is brought on by an imbalance between dangerous free radicals and antioxidant defenses. Strong antioxidants work to scavenge free radicals and lessen oxidative stress. Supplementation may help maintain cellular integrity, slow aging, and lower the risk of age-related disorders by minimizing oxidative damage to cellular components.

An increased risk of cardiovascular illnesses commonly coexists with aging. It promotes heart health by increasing the energy generation of cardiac cells, lowering oxidative stress and boosting blood vessel function. Supplements may help maintain healthy blood pressure, preserve good cardiovascular function and lower the risk of developing aging-related cardiovascular diseases.

The potential benefits of supplementation for promoting brain health and preventing neurodegenerative diseases have been demonstrated. It can boost brain cell mitochondrial activity, lessen oxidative stress and improve cognitive performance.

Coq10 is essential for preserving the health and look of young skin. It promotes collagen synthesis, offers UV protection and lessens oxidative stress in the skin. People who use coq10 supplements may notice better skin elasticity, fewer wrinkles, and a youthful appearance.

They target a key enzymatic step along the mevalonate pathway, involved in the synthesis of both cholesterol and isoprenylated compounds including CoQ On the contrary, at lower statin concentrations, cells and mainly mitochondria, are able to partially adapt and prevent oxidative imbalance and overt mitochondrial toxicity.

Importantly, our data demonstrate that CoQ 10 decrease promotes mitochondrial permeability transition and bioenergetic dysfunction leading to premature aging of human dermal fibroblasts in vitro. Coenzyme Q CoQ 10 is a lipophilic endogenous isoprenylated quinone widely distributed and conserved in living organisms.

In human beings, the isoprenoid chain is composed of 10 units CoQ Due to its ubiquitous presence in cellular membranes, it is also referred to as ubiquinone; in fact, it is present in lipoproteins as well as cellular and intracellular membranes.

CoQ 10 has two main biological functions: it supports mitochondrial bioenergetics and in its reduced form, ubiquinol, it is a phenolic antioxidant that acts as an electron donor effective in inhibiting lipid peroxidation of biological membranes as well as exerting anti-apoptotic activity [ 1 ].

In fact, CoQ 10 in its reduced form ubiquinol CoQ 10 H 2 , is a potent antioxidant in the lipophilic environment, both by directly scavenging ROS and also by regenerating lipophilic and hydrophilic antioxidants such as tocopherol and vitamin C. Moreover, plasma membrane CoQ 10 H 2 has been shown to exert an anti-apoptotic effect by counteracting the release of ceramide from sphingomyelin, hence regulating the extracellularly-induced ceramide-dependent programmed cell death pathway [ 2 ].

In this respect, Plasma Membrane Reductive Systems PMRS play a major role in activating CoQ 10 through enzymatic two electron reduction catalyzed by dehydrogenase enzymes, mainly NADH-cytochrome b5 reductase and NAD P H: quinone reductase 1 NQO1.

This activity is influenced by the aging process and by pro-oxidant stimuli that may decrease the activity of membrane CoQ 10 reductive systems [ 3 ]. In contrast, caloric restriction CR has been shown to up-regulate the plasma membrane redox system in brain cells and to suppress oxidative stress during aging.

Moreover, recent studies have shown that over-expression of NQO1 in transgenic mice, was able to mimic the effects of CR by decreasing the levels of inflammation and neoplastic proliferation as well as enhancing bioenergetic activity [ 4 ].

The dynamics of the electron transfer, that was originally defined in a random collision model, has been recently updated by the identification of respiratory supercomplexes comprising complexes I and III [ 5 , 6 ].

In this updated view, part of mitochondrial CoQ 10 is bound within supercomplexes where electron transfer would be mediated by tunneling or microdiffusion, with a clear kinetic advantage.

CoQ 10 content in mitochondria is in large excess compared to the prosthetic groups of respiratory enzymes [ 7 ] and the un-bound mitochondria CoQ 10 pool, besides constituting a reservoir for bioenergetic requirements and an antioxidant for mitochondrial membrane lipids, is able to modulate bioenergetic processes and cell death pathways by binding to specific proteins, such as uncoupling proteins UCPs [ 8 ] and the permeability transition pore PTP [ 9 ].

Early reports identified physiological concentrations of CoQ 10 in mitochondria in the range of the Km of the respiratory complex I and II. This led to the conclusion that slight variations in CoQ 10 content may produce significant effects on the efficiency of the mitochondrial respiratory chain [ 10 ].

Recent evidence supporting the existence of respiratory chain complexes in supermolecular assemblies, called supercomplexes or respirasomes, partially challenges this view in light of optimization of electron transfer processes in comparison to the random collision hypothesis; nonetheless, it is also believed that CoQ 10 content is in a dynamic equilibrium between the free CoQ 10 pool and the supercomplex-bound form.

As a consequence, mitochondrial CoQ 10 -pool decrease should also influence respiratory efficiency. In fact, decrease in CoQ 10 content is known to occur in conditions associated both with oxidative stress and mitochondrial dysfunction such as degenerative pathologies and in physiological conditions during the aging process with organ specific differences [ 11 ] both in animal models [ 12 ] and in humans [ 13 , 14 ].

Moreover, CoQ 10 supplementation has been shown to be effective in reverting senescent phenotype features in in vitro models as well as in animal and human interventions studies.

In this respect recent studies have shown that CoQ 10 supplementation was able to counteract oxidative stress and inflammatory responses in senescent endothelial cells as well as decrease the expression of SASPs Senescence Associated Secretory Phenotype genes [ 15 , 16 ].

Co-treatment of CoQ 10 and physical exercise in senescence accelerated mice SAMP8 was efficient in slowing down degenerative processes in skeletal muscle cells by protecting mitochondria structure and function and inducing mitochondrial biogenesis [ 17 ].

Furthermore, stress-induced accelerated senescence in CoQ 10 supplemented mice was able to decrease senescence markers, oxidative stress and fibrotic tissue remodeling in cardiac tissue [ 18 , 19 ]. Both antioxidant and bioenergetic roles of CoQ 10 are therefore deeply related with the aging process.

In fact, mitochondria are a critical site representing both a source and a target of reactive oxygen species ROS. During cellular senescence, increased ROS release by mitochondria might trigger a vicious cycle involving accumulation of oxidative damage to mitochondrial membranes and respiratory complexes leading to enhanced ROS production [].

This condition is associated with dynamic rearrangements of mitochondria, that in virtue of their elevated plasticity, are able to modulate their morphology and functionality in response to stress [ 23 ]. In particular, low levels of stress are able to activate signaling pathways through the activation of redox-sensitive transcription factors such as NRF2 that is involved in the transcription of detoxifying and antioxidant enzymes [ 24 ].

Chronic levels of stress however, result in extensive fragmentation of mitochondria, decrease in their copy number and lowered respiratory capacity [ 25 , 26 ]. Ultimately, mitochondria accumulating excessive damage are able to trigger apoptotic cell death processes, further stressing the pivotal role of these organelles in cellular life and death.

In relation to these aspects, both bioenergetic and antioxidant functions of CoQ 10 are relevant to maintain mitochondrial functionality and to prevent age-associated damage.

The human skin, due to its function as interface with external environment, is more exposed than other tissues to damaging pro-oxidant stimuli, such as high oxygen tension, ultraviolet radiation, and pollution, that enhance cellular oxidative stress and accelerate senescence processes.

Notably, CoQ 10 content in the epidermis, the outermost layer of the skin, is up to ten times higher compared to the adjacent dermis [ 28 ]. Exogenous CoQ 10 supplementation significantly protects from mitochondrial dysfunction and oxidative damage in vitro in photo-exposed keratinocytes and dermal fibroblasts.

Moreover, topical application in healthy human subjects revealed significant photoprotection and amelioration of the features of aged skin [ 29 , 32 ]. CoQ 10 cellular content can also be influenced by drugs interfering with its biosynthesis.

Endogenous biosynthesis of CoQ 10 is linked to the mevalonate pathway Fig. Along this pathway, HMG-CoA reductase is a key enzyme regulating the synthesis of cholesterol as well as of CoQ 10 , dolichols and prenylated proteins. Dermal fibroblasts acquire exogenous cholesterol from adsorptive endocytosis of plasma low density lipoproteins LDL but are also able of endogenous biosynthesis through the mevalonate pathway [ 33 ].

Statins are selective inhibitors of HMG-CoA reductases widely used as hypocholesterolemic drugs in cardiovascular disease prevention. Although they are generally well tolerated at high doses, they may produce serious adverse effects such as rhabdomyolysis [ 20 , 34 , 35 ].

Several experimental evidence in cell culture and animal models link statin toxicity to mitochondrial impairment involving bioenergetics dysfunctions, enhanced oxidative stress, altered calcium homeostasis and programmed cell death activation [].

While some recent data points out that simvastatin exerts a direct inhibitory effect on complex III [ 39 ] CoQ 10 deprivation has clearly also a strong impact in producing these effects.

The aim of the present work is to establish a model of CoQ 10 deprivation in human dermal fibroblasts in order to monitor how this affects intracellular oxidative status and mitochondrial functionality and to verify whether lowering CoQ 10 levels is associated with the onset of senescence.

Simvastatin influences CoQ 10 content and oxidative status in a dose-dependent manner Fig. Effect of simvastatin on cellular CoQ 10 levels and cytotoxicity. Viability A and CoQ 10 content and oxidative status B of human dermal fibroblasts with different doses of simvastatin for 72 h.

Figure 3. Effect of simvastatin on reactive oxygen species ROS levels and nuclear factor erythroid-derived 2 -like 2 NRF2 translocation. A Flow cytometric distribution of cells according to their cellular DCF and mitochondrial matrix Mitosox ROS content in a reference experiment to define gates relative to low and high ROS respectively.

C Nuclear translocation of NRF2 in simvastatin treated samples for 72 h 20 and 40 nM and unexposed control. Data are expressed as ratio of NRF2-FITC associated green fluorescence in the nucleus and cytoplasm.

Increasing the concentration of statin over nM, results in a progressive increase in cellular ROS with a population characterized by LOW ROS content comparable with the unexposed control up to nM.

Interestingly, at these higher concentrations mitochondrial superoxide production is also significantly higher than in untreated control cells; whereas in the intermediate range of exposure between nM and nM mitochondrial superoxide release remains unchanged compared to untreated cells Fig.

Altered cellular oxidative status is able to promote stress induced premature senescence as documented by a dose-dependent increase in ß-gal positivity, with significant differences compared to control cells at concentrations of and nM simvastatin Fig.

These data are confirmed at molecular level by a significant increase in the expression of p16 mRNA Fig. Figure 4. Simvastatin promotes senescence markers of cellular senescence in human dermal fibroblasts incubated with different doses of simvastatin for 72 h.

Beta-galactosidase positive cells A. p16 mRNA expression B ; western blot analysis of p16 C, D. A closer analysis of mitochondrial parameters shows that in relation to CoQ 10 deprivation, mitochondria undergo relevant changes in their functionality and biogenesis. In particular, in the presence of nM simvastatin a significant mitochondrial transition pore opening is observed.

This stress reaction is characterized by a wide distribution of cells indicating a heterogeneous behavior. Notably, mPTP opening increases dose-dependently up to nM Fig.

Figure 5. Effect of simvastatin on mitochondrial toxicity. Permeability transition pore opening A and mtDNA copy number B in human dermal fibroblasts in presence of different concentrations of simvastatin for 72 h. Figure 6. Respiratory profile in control and statin-treated fibroblasts.

The data show that simvastatin is able to decrease basal respiration Fig. Effect of simvastatin on mitochondrial respiratory indexes.

Respiratory profile of human dermal fibroblasts incubated with different concentrations of simvastatin for 72 h. Non-mitochondrial respiration A , basal respiration B , maximal respiration C , proton leakage D , ATP production E , spare respiratory capacity F. Overall, spare respiratory capacity Fig.

Non-mitochondrial respiration and proton leakage Fig. Mitochondrial protein interaction mapping identifies regulators of respiratory chain function. Cell 63, — Fotino, A. Effect of coenzyme Q 1 0 supplementation on heart failure: a meta-analysis.

Freyer, C. Rescue of primary ubiquinone deficiency due to a novel COQ7 defect using 2,4-dihydroxybensoic acid. Galasko, D.

Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures.

Genova, M. Functional role of mitochondrial respiratory supercomplexes. Gigante, M. Further phenotypic heterogeneity of CoQ10 deficiency associated with steroid resistant nephrotic syndrome and novel COQ2 and COQ6 variants.

Gonzalez-Guardia, L. Effects of the Mediterranean diet supplemented with coenzyme q10 on metabolomic profiles in elderly men and women. A Biol. Gorman, G. Mitochondrial diseases. Primers Grimm, A. Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer's disease.

Biogerontology 17, — Guaras, A. Cell Rep. Guo, R. Architecture of human mitochondrial respiratory megacomplex I2III2IV2. Cell , e— e Gvozdjakova, A.

Coenzyme Q 1 0 , alpha-tocopherol, and oxidative stress could be important metabolic biomarkers of male infertility. Markers CrossRef Full Text.

Ubiquinol improves symptoms in children with autism. Hamilton, S. Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients.

Diabetes Care 32, — Hathcock, J. Risk assessment for coenzyme Q10 Ubiquinone. He, C. Human COQ9 rescues a coq9 yeast mutant by enhancing coenzyme Q biosynthesis from 4-hydroxybenzoic acid and stabilizing the CoQ-synthome.

Coenzyme Q supplementation or over-expression of the yeast Coq8 putative kinase stabilizes multi-subunit Coq polypeptide complexes in yeast coq null mutants. Heeringa, S. COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. Ishikawa, A.

Renal preservation effect of ubiquinol, the reduced form of coenzyme Q Ishrat, T. Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats.

Brain Res. Jakobs, B. A novel mutation in COQ2 leading to fatal infantile multisystem disease. Johansson, P. Improved health-related quality of life, and more days out of hospital with supplementation with selenium and coenzyme Q10 combined.

Results from a double blind, placebo-controlled prospective study. Health Aging 19, — Kalen, A. Age-related changes in the lipid compositions of rat and human tissues. Lipids 24, — Kawamukai, M.

Biosynthesis of coenzyme Q in eukaryotes. Lafuente, R. Coenzyme Q10 and male infertility: a meta-analysis. Lapointe, J. Lapuente-Brun, E.

Supercomplex assembly determines electron flux in the mitochondrial electron transport chain. Science , — Laredj, L. The molecular genetics of coenzyme Q biosynthesis in health and disease. Biochimie , 78— Law, M. Statin safety: a systematic review. Littarru, G. Coenzyme Q10 and statins: biochemical and clinical implications.

Mitochondrion 7 Suppl. Liu, J. Mitochondrial enhancement for neurodegenerative movement disorders: a systematic review of trials involving creatine, coenzyme Q10, idebenone and mitoquinone. CNS Drugs 28, 63— Coenzyme Q10 for Parkinson's disease. López-Lluch, G.

Mouse liver plasma membrane redox system activity is altered by aging and modulated by calorie restriction. Age 27, — Is coenzyme Q a key factor in aging? Madmani, M. Coenzyme Q10 for heart failure. Martin-Montalvo, A. The phosphatase Ptc7 induces coenzyme Q biosynthesis by activating the hydroxylase Coq7 in yeast.

Cytochrome b5 reductase and the control of lipid metabolism and healthspan. NPJ Aging Mech. Mazidi, M. Effects of coenzyme Q10 supplementation on plasma C-reactive protein concentrations: A systematic review and meta-analysis of randomized controlled trials.

PubMed Abstract CrossRef Full Text. McGarry, A. A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology 88, — Milenkovic, D. The enigma of the respiratory chain supercomplex.

Cell Metab. Mischley, L. Coenzyme Q10 deficiency in patients with Parkinson's disease. Molyneux, S. The bioavailability of coenzyme Q10 supplements available in New Zealand differs markedly.

PubMed Abstract Google Scholar. Montini, G. Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. Moradi, M. Effect of coenzyme Q10 supplementation on diabetes biomarkers: a systematic review and meta-analysis of randomized controlled clinical trials.

Morgenstern, M. Definition of a high-confidence mitochondrial proteome at quantitative scale. Mortensen, S. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.

JACC Heart Fail. Navas, P. The importance of plasma membrane coenzyme Q in aging and stress responses. Negida, A. Coenzyme Q10 for patients with parkinson's disease: a systematic review and meta-analysis. CNS Neurol. Drug Targets 15, 45— Perez-Sanchez, C.

Ubiquinol effects on antiphospholipid syndrome prothrombotic profile: a randomized, placebo-controlled trial.

Pineda, M. Coenzyme Q 10 -responsive ataxia: 2-year-treatment follow-up. Pirro, M. The effects of a nutraceutical combination on plasma lipids and glucose: a systematic review and meta-analysis of randomized controlled trials.

Rivara, M. Effect of coenzyme Q10 on biomarkers of oxidative stress and cardiac function in hemodialysis patients: the CoQ10 biomarker trial. Kidney Dis. Rodriguez-Aguilera, J. Biochemical assessment of coenzyme Q 10 deficiency. Ross, D. Functions of NQO1 in cellular protection and CoQ10 metabolism and its potential role as a redox sensitive molecular switch.

Rossignol, D. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Psychiatry 17, — Safarinejad, M.

Effects of the reduced form of coenzyme Q10 ubiquinol on semen parameters in men with idiopathic infertility: a double-blind, placebo controlled, randomized study. Sahebkar, A. Supplementation with coenzyme Q10 reduces plasma lipoprotein a concentrations but not other lipid indices: a systematic review and meta-analysis.

Saiki, R. Renal Physiol. Salviati, L. Pagon, M. Adam, H. Ardinger, S. Wallace, A. Amemiya, L. Bean, et al. Seattle, WA: University of Washington. Google Scholar. Haploinsufficiency of COQ4 causes coenzyme Q10 deficiency. Santos-Ocana, C. Uptake of exogenous coenzyme Q and transport to mitochondria is required for bc1 complex stability in yeast coq mutants.

Schirris, T. Statin-induced myopathy is associated with mitochondrial complex III inhibition. Schmelzer, C. Supplementation with the reduced form of Coenzyme Q10 decelerates phenotypic characteristics of senescence and induces a peroxisome proliferator-activated receptor-alpha gene expression signature in SAMP1 mice.

Marcheggiani FCoenzyme Q aging AgihgOrlando PSilvestri Hydration for sports performance optimizationVogelsang AKnott Coenzyje Coenzyme Q aging, Blatt TWeise AgintTiano L. Modulation Coenzyme Q aging Coenzyme Q 10 content and oxidative status in human dermal fibroblasts using HMG-CoA reductase inhibitor over a broad range of concentrations. From mitohormesis to mitochondrial dysfunction and accelerated aging. Aging Albany NY. Copyright: Marcheggiani et al. Coenzyme Q 10 CoQ 10 is an endogenous lipophilic quinone, ubiquitous in biological membranes and endowed with antioxidant and bioenergetic properties, both crucial to the aging process.

Author: Arakus

2 thoughts on “Coenzyme Q aging

Leave a comment

Yours email will be published. Important fields a marked *

Design by ThemesDNA.com